Injectable Metoclopramide Dosage
The recommended injectable metoclopramide dosage is 10 mg IV administered slowly over 1-2 minutes for most indications, with higher doses of 1-2 mg/kg IV (up to 2 mg/kg for highly emetogenic chemotherapy) used specifically for chemotherapy-induced nausea and vomiting. 1
Standard Dosing by Indication
Diabetic Gastroparesis
- 10 mg IV administered slowly over 1-2 minutes
- May be given intramuscularly as alternative route
- Can be repeated every 6-8 hours as needed
- Treatment may continue up to 10 days before transitioning to oral therapy 1
Chemotherapy-Induced Nausea and Vomiting (CINV)
For highly emetogenic chemotherapy (e.g., cisplatin):
- 2 mg/kg IV infused over at least 15 minutes
- Given 30 minutes before chemotherapy
- Repeated every 2 hours for 2 doses, then every 3 hours for 3 doses
- Must be diluted in 50 mL parenteral solution (preferably normal saline) for doses exceeding 10 mg 1
For moderately emetogenic chemotherapy:
- 1 mg/kg IV per dose may be adequate
- Same timing schedule as above 1
For breakthrough CINV:
- 10-20 mg IV every 4-6 hours as rescue therapy 2
The evidence strongly supports dose-response relationships for chemotherapy-induced emesis. Studies demonstrate that 2 mg/kg doses provide superior antiemetic control compared to lower doses, with one randomized trial showing significant reduction in emetic episodes (average of 5-8 episodes with 2-8 mg/kg versus 16 episodes with 1 mg/kg) 3. However, antiemetic efficacy plateaus above 2 mg/kg, making higher doses unnecessary 3, 4.
Postoperative Nausea and Vomiting
- 10 mg IM (or up to 20 mg) given near the end of surgery 1
Small Bowel Intubation
- Adults and pediatrics >14 years: 10 mg IV undiluted over 1-2 minutes
- Pediatrics 6-14 years: 2.5-5 mg IV
- Pediatrics <6 years: 0.1 mg/kg IV 1
Radiological Examinations
- Same dosing as small bowel intubation above 1
Critical Dosing Adjustments
Renal Impairment
For creatinine clearance <40 mL/min: Initiate at approximately one-half the recommended dosage, then titrate based on efficacy and tolerability 1. This is essential because metoclopramide is primarily renally excreted (approximately 85% eliminated in urine within 72 hours) 1.
Hepatic Impairment
Minimal dosage adjustment needed as metoclopramide undergoes minimal hepatic metabolism beyond simple conjugation 1.
Administration Technique
- IV push: Administer slowly over 1-2 minutes for standard 10 mg doses
- IV infusion: Administer over minimum 15 minutes for chemotherapy doses
- Dilution: Required for doses >10 mg in 50 mL normal saline (preferred), D5W, or other compatible solutions
- Storage: Diluted solutions stable for 48 hours protected from light, or 24 hours under normal light 1
Important Safety Considerations
Extrapyramidal reactions: If acute dystonic reactions occur, immediately administer 50 mg diphenhydramine IM 1. These reactions are more common with higher doses but can occur at any dose level.
Pediatric dosing caution: The youngest patients (especially <3.5 weeks) demonstrate significantly prolonged half-lives (up to 23 hours) due to immature hepatic and renal systems, requiring careful monitoring 1.
The guidelines from ASCO and NCCN position metoclopramide as a rescue or breakthrough agent rather than first-line prophylaxis for CINV, with 5-HT3 antagonists, NK1 receptor antagonists, and corticosteroids preferred for primary prevention 5, 2. However, for radiation-induced nausea with low to minimal emetic risk, metoclopramide 5-20 mg IV remains an acceptable option 5.